Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00685347 · ClinicalTrials.gov registry record · Phase 2

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects

A Phase 2 study of Asthma and Bronchoconstriction, sponsored by Sumitomo Pharma America.

Completed
Registry status
Phase 2
Development phase
33
Enrollment target
6
Study locations

NCT00685347 is a Phase 2 study of Asthma and Bronchoconstriction that has completed, run by Sumitomo Pharma America. The registered enrollment target is 33 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00685347, a Phase 2 study of Asthma and Bronchoconstriction, has completed, sponsored by Sumitomo Pharma America.

COMPLETED
Registry status
Phase 2
Development phase
33 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to investigate, using an exercise challenge approach, the dose response of levalbuterol HFA MDI in pediatric subjects with asthma

Conditions Studied

Asthma Bronchoconstriction

Interventions

  • DRUG Levalbuterol HFA MDI
  • DRUG Racemic Albuterol

Study Locations (6)

Colorado

  • - Denver
  • - Englewood

California

  • - Long Beach

Massachusetts

  • - Russells Mills

Texas

  • - Dallas

Virginia

  • - Burke

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2003-01
Est. Completion 2003-06
Phase Phase 2

Sponsor

Sumitomo Pharma America

168 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00685347

The ClinicalTrials.gov registry entry for NCT00685347 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Levalbuterol HFA MDI is the first listed.

NCT00685347 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Colorado, California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00685347 about?

NCT00685347 is a clinical study titled "Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects". The purpose of this study is to investigate, using an exercise challenge approach, the dose response of levalbuterol HFA MDI in pediatric subjects with asthma

What is the current status of trial NCT00685347?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2003-01. Estimated completion is 2003-06.

What conditions does trial NCT00685347 study?

This clinical trial studies the following conditions: Asthma, Bronchoconstriction.

What interventions are being tested in trial NCT00685347?

The interventions under investigation include: Levalbuterol HFA MDI (DRUG), Racemic Albuterol (DRUG).

Who is sponsoring clinical trial NCT00685347?

This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00685347 being conducted?

This trial has 6 study locations across California, Colorado, Massachusetts, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Bronchoconstriction

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.